ODDB.org: Open Drug Database

Avastin 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung - Durchstechflasche(n)

Swissmedic Key	56922003	Registration Holder	Roche Pharma (Schweiz) AG
Name	Avastin 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	16.12.2004
Original/Generic	Original	Introduction of Sequence	16.12.2004
ATC-Classification	Bevacizumab (L01FG01)	Revision date	17.12.2007
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	70000.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	1034.26	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	1136.85
Feedback	FB
GTIN	7680569220038	Medication Code	Biotechnologika
Pharmacode	2918914	Disponibility

Composition

bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 21.664 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	400mg / 16ml

BAG: Active Agent	Dose
Bevacizumab	400 mg

Inactive agents
Disodium Phosphate
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
Trehalosum Dihydricum

Source

Data was imported : 08.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2026	©ywesee GmbH